[Experience with gliatilin treatment of patients with intracranial neoplasia].
Kondrat'ev
A N
AN
Lesina
S S
SS
Kondrat'eva
E A
EA
Nazarov
P V
PV
D000109:Acetylcholine / Q000378:metabolism*; D000328:Adult; D000368:Aged; D001812:Blood-Brain Barrier / Q000187:drug effects; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology* / Q000523:psychology / Q000601:surgery; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003071:Cognition / Q000187:drug effects; D005260:Female; D005997:Glycerylphosphorylcholine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009473:Neuronal Plasticity / Q000187:drug effects; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D005997:Glycerylphosphorylcholine; D000109:Acetylcholine